Vancomycin pharmacokinetics in patients with various degrees of renal function.
about
Pharmacokinetics of vancomycin in oncology egyptian paediatrics: a dosage adjustment trialOutcome assessment of minimizing vancomycin monitoring and dosing adjustments.Vancomycin revisited - 60 years laterCurrent recommended dosing of vancomycin for children with invasive methicillin-resistant Staphylococcus aureus infections is inadequate.Pharmacokinetics of vancomycin in adult cystic fibrosis patients.Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding.Vancomycin pharmacokinetics in burn patients and intravenous drug abusersApplication of a Bayesian method to monitor and adjust vancomycin dosage regimensProtein binding of vancomycin in a patient with immunoglobulin A myeloma.Influence of renal function estimation on pharmacokinetic modeling of vancomycin in elderly patientsVancomycin AUC24/MIC ratio in patients with complicated bacteremia and infective endocarditis due to methicillin-resistant Staphylococcus aureus and its association with attributable mortality during hospitalizationEffect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique.Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenationPredictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation.Vancomycin pharmacokinetics in preterm neonates and the prediction of adult clearanceThe pharmacokinetic and pharmacodynamic properties of vancomycin.Are vancomycin trough concentrations adequate for optimal dosing?Underestimation of the calculated area under the concentration-time curve based on serum creatinine for vancomycin dosing.Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.Evaluation of Treatment Courses When Vancomycin Is Given Every 8 Hours in Adult Patients.Pharmacokinetics and pharmacodynamics of antibacterial and antifungal agents in adult patients with thermal injury: a review of current literature.Vancomycin pharmacokinetic models: informing the clinical management of drug-resistant bacterial infections.Pediatric Assessment of Vancomycin Empiric Dosing (PAVED): a Retrospective Review.Overestimation of Vancomycin Clearance by the Linear Regression Formula in Rodvold's Report: Why?Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia.Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia.Pilot Study of a Bayesian Approach To Estimate Vancomycin Exposure in Obese Patients with Limited Pharmacokinetic Sampling.Intravenous Vancomycin Dosing in the Elderly: A Focus on Clinical Issues and Practical Application.A Strategy for Dosing Vancomycin to Therapeutic Targets Using Only Trough Concentrations.Serum protein-binding characteristics of vancomycin.Population pharmacokinetic parameters of vancomycin in critically ill patients.Teicoplanin or vancomycin in the treatment of gram-positive infections?Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model.Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.Comparison of vancomycin pharmacokinetics in hospitalized elderly and young patients using a Bayesian forecaster.Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections.Initial dosing regimen of vancomycin to achieve early therapeutic plasma concentration in critically ill patients with MRSA infection based on APACHE II score.Peak Measurement for Vancomycin AUC Estimation in Obese Adults Improves Precision and Lowers Bias.Methodological Study of Vancomycin Dosing in Elderly Patients Using Actual Serum Creatinine Versus Rounded Serum Creatinine.
P2860
Q33555334-0052F1D1-88A2-4E80-9B8B-51FCC3FD0CD5Q33860155-B66530CE-D1A9-4AD4-A5BA-E83B09DC556CQ34433066-29DCC29D-5934-41D5-A9E3-27630931F974Q35004264-ADBC987A-406B-4008-B8BE-CCB5EB3E368CQ35121949-B935E7B3-6234-4FF4-A92D-4C4631405028Q35191519-4A5CFD40-FE8E-4844-96E3-D6F4916CAB9BQ35253581-20FCE1CB-0BB4-4875-ACB1-6580558912AEQ35261758-A706E606-6793-4AC2-9277-CDE228D210CCQ35565490-710621D2-D9F6-41E7-BA6E-6DFBB43ECCEFQ35607704-1E361B21-ED8D-4CE1-9782-F83EF7ECC794Q35689318-81598C92-A07F-44EF-826C-C8EF08989CCFQ35809992-0405CAFD-FD83-4A36-A477-1DC421E8940BQ35826801-44C3FEBF-E52F-4309-A42A-C6EE50FB0492Q35993369-AA9A77BD-9D18-43CA-B91D-6BAA02251620Q36024899-2188D231-AF58-4431-99A5-A45A0D33378AQ36328971-D8A55D19-F1CC-4509-AA11-476ADA86A632Q37544400-83875D3A-EBA3-4557-A4F1-7F15C77FF535Q37673492-283466B6-EE77-437F-82F6-10C9C9317627Q37989803-B5420641-1221-41F9-AA85-85BF935B2642Q38238908-81746E30-F73F-4B57-B66F-AC25ACEF2D62Q38244221-664E1F45-3EAD-4851-8753-01D7B6FAF601Q38258649-B6AB58B2-DCBD-44EE-A273-D7DD19695EB4Q38392526-B14E03A3-48FA-43D2-88B3-7E2368AA1745Q38563954-22F035D0-0FD3-4718-A4FF-938E4452AFFFQ38780029-FC439EBE-58A9-4C5C-B96E-614BCCEF68ACQ38825167-845176C2-73DD-4F85-B120-1A132AD29308Q38910495-00D649D1-C9D0-4E09-B37C-53D126752A5DQ39017701-8380F7E3-F106-4B90-B79F-3923C4C970EAQ39623184-9510CEBC-F839-49C7-B454-B85C394FFBE9Q39866031-7196CA57-5437-4443-BF61-D9646A224D67Q40290397-A54A0DFA-5035-4ABC-A7A2-B0EA7F6E57CFQ40541603-79791C9B-2BB4-4208-88A8-E061B07B5AB8Q40601946-57B56609-7EA9-4019-B502-391CA0A699F2Q40716347-6E4B4EAD-2806-4B7C-9448-227335FADA09Q41032517-B08DD9BE-E80A-426A-A2C6-E9D3C526431BQ41066696-CA392452-5976-46AE-9A4B-5EC83DB55534Q41508527-E850E16A-42C6-47CF-820F-4DADEB9AEA70Q41601693-5D6EEE53-A568-4E04-851E-8CED27F2CE4EQ41695499-18C526D7-5B5B-4C31-BA01-A189DAA5D5FBQ42370963-7E2120C4-F5B1-4194-96F1-3FBEE236D018
P2860
Vancomycin pharmacokinetics in patients with various degrees of renal function.
description
1988 nî lūn-bûn
@nan
1988 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@ast
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@en
type
label
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@ast
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@en
prefLabel
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@ast
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@en
P2093
P2860
P356
P1476
Vancomycin pharmacokinetics in patients with various degrees of renal function.
@en
P2093
Crossley KB
Fischer JH
Rodvold KA
Rotschafer JC
P2860
P304
P356
10.1128/AAC.32.6.848
P407
P577
1988-06-01T00:00:00Z